TY - JOUR
T1 - 4-Alkyl and 4,4′-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5- dione derivatives as new inhibitors of bacterial cell wall biosynthesis
AU - Kutterer, Kristina M.K.
AU - Davis, Jamie M.
AU - Singh, Guy
AU - Yang, Youjun
AU - Hu, William
AU - Severin, Anatoly
AU - Rasmussen, Beth A.
AU - Krishnamurthy, Girija
AU - Failli, Amedeo
AU - Katz, Alan H.
PY - 2005/5/16
Y1 - 2005/5/16
N2 - Over 195 4-alkyl and 4,4-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5- dione derivatives were synthesized, utilizing microwave accelerated synthesis, for evaluation as new inhibitors of bacterial cell wall biosynthesis. Many of them demonstrated good activity against MurB in vitro and low MIC values against Gram-positive bacteria, particularly penicillin-resistant Streptococcus pneumoniae (PRSP). Derivative 7l demonstrated antibacterial activity against both Gram-positive and Gram-negative bacteria. Derivatives 7f and 10a also demonstrated potent nanomolar Kd values in their binding to MurB.
AB - Over 195 4-alkyl and 4,4-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5- dione derivatives were synthesized, utilizing microwave accelerated synthesis, for evaluation as new inhibitors of bacterial cell wall biosynthesis. Many of them demonstrated good activity against MurB in vitro and low MIC values against Gram-positive bacteria, particularly penicillin-resistant Streptococcus pneumoniae (PRSP). Derivative 7l demonstrated antibacterial activity against both Gram-positive and Gram-negative bacteria. Derivatives 7f and 10a also demonstrated potent nanomolar Kd values in their binding to MurB.
KW - Antibacterial activity
KW - Microwave-assisted synthesis
KW - MurA
KW - MurB
KW - Pyrazolidinediones
UR - http://www.scopus.com/inward/record.url?scp=20944432485&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2005.03.058
DO - 10.1016/j.bmcl.2005.03.058
M3 - Article
C2 - 15863310
AN - SCOPUS:20944432485
SN - 0960-894X
VL - 15
SP - 2527
EP - 2531
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 10
ER -